Please check your internet connection and try again.
# Magnesium Sulphate
## Overview
Magnesium sulphate is an inorganic salt that acts as an essential mineral and an anticonvulsant.
## Primary Indications
* Treatment of hypomagnesemia.
* Prevention and treatment of eclampsia and pre-eclampsia.
* Management of torsades de pointes.
* Treatment of status epilepticus refractory to other agents.
## Adult Dosing
* **Hypomagnesemia:**
* Mild deficiency: 1 gram (8 mmol) diluted in 100 mL normal saline or D5W infused IV over 5-10 minutes, repeated every 4 hours as needed, or 1 gram (8 mmol) IM every 6 hours for 4 doses.
* Severe deficiency: 4-5 grams (32-40 mmol) diluted in 250-1000 mL IV fluid infused over 12-24 hours. Maintenance infusions vary based on serum magnesium levels.
* **Eclampsia/Pre-eclampsia (loading dose):** 4-6 grams (32-48 mmol) diluted in 100 mL IV fluid infused over 15-20 minutes.
* **Eclampsia/Pre-eclampsia (maintenance dose):** 1-2 grams (8-16 mmol) per hour infused IV. Specific infusion rates may vary by protocol.
* **Torsades de Pointes:** 1-2 grams (8-16 mmol) diluted in 10 mL IV fluid infused IV over 5-10 minutes. May be followed by an infusion of 2 grams (16 mmol) per hour.
* **Status Epilepticus (refractory):** 2-4 grams (16-32 mmol) diluted in 100-200 mL IV fluid infused IV over 10-15 minutes.
Maximum dose is typically dictated by patient response and tolerance, but caution is advised to avoid hypermagnesemia.
## Pediatric Dosing
Dosing is highly variable and often based on local protocols and specific indication.
* **Hypomagnesemia:** Typically 20-50 mg/kg/dose (elemental magnesium) IV infused over 10-30 minutes, not to exceed 2 grams per dose. May be repeated every 4-12 hours.
* **Eclampsia/Pre-eclampsia:** Often follows adult guidelines with appropriate weight-based adjustments for loading and maintenance doses.
Consult specific pediatric guidelines for precise dosing.
## Dose Adjustments
* **Renal Impairment:** Use with extreme caution. Magnesium is renally excreted. Reduced doses and careful monitoring are necessary. Severe renal impairment may preclude its use.
## Contraindications
* Hypermagnesemia.
* Heart block (unless a temporary pacemaker is in place).
* Myocardial infarction.
* Hyperkalemia.
* Renal failure (use with caution).
## Adverse Effects
* Flushing, sweating, hypotension, nausea, vomiting, decreased deep tendon reflexes, somnolence, muscle weakness, respiratory depression, cardiac arrhythmias, and cardiac arrest.
* Hypermagnesemia: Lethargy, hyporeflexia, muscle weakness, difficulty breathing, cardiac arrest.
## Key Drug Interactions
* **Neuromuscular Blockers:** Potentiates neuromuscular blockade.
* **Calcium Channel Blockers:** Increased risk of hypotension and bradycardia.
* **Tetracyclines and Quinolone Antibiotics:** Magnesium can decrease the absorption of these agents. Administer at least 2 hours before or 4-6 hours after magnesium.
* **Bisphosphonates:** Magnesium can decrease absorption. Administer at least 2 hours before or 6 hours after magnesium.
## Monitoring
* **Serum magnesium levels:** Monitor closely, especially during infusions and in patients with renal impairment. Therapeutic levels for eclampsia are typically 4-7 mEq/L.
* **Renal function:** Monitor creatinine and BUN.
* **Deep tendon reflexes:** Assess for loss of reflexes, which can indicate toxicity.
* **Respiratory rate and effort:** Monitor for signs of respiratory depression.
* **Cardiac rhythm:** Monitor for arrhythmias.
* **Blood pressure:** Monitor for hypotension.
## Clinical Pearls
* Magnesium sulphate should be administered slowly to avoid hypotension and flushing.
* Antidote for magnesium toxicity is IV calcium (e.g., calcium gluconate).
* In pregnant patients with pre-eclampsia/eclampsia, monitor urine output closely (aim for >30 mL/hr), as reduced output can lead to magnesium accumulation.
* Always ensure adequate IV access and resuscitation equipment are readily available.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before administering any medication.